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Abstract
Background: Endothelial dysfunction precedes structural abnormali-
ties and atherosclerosis clinical manifestations, and thus it is conside-
red an early marker of cardiovascular diseases. The objectives of this 
cross-sectional study were to determine the frequency of endothelial 
dysfunction in prehypertensive subjects and its association with demo-
graphic, anthropometric and clinical characteristics of the population 
studied. 
Methods and Results: Endothelial function was assessed by flow-
mediated vasodilation (FMD) of the brachial artery in 60 non-smoking 
and non-diabetic prehypertensive subjects aged 30-70 years who were 
recruited from the community. Variables analyzed were gender, age, 
race, sedentary lifestyle, dyslipidemia, body mass index, abdominal 
circumference and blood pressure. In order to evaluate the relation-
ship between endothelial dysfunction and study variables, Student t, 
Mann-Whitney and chi-square tests were used. Multivariate logistic re-
gression of variables analyzed with respect to endothelial dysfunction 
was applied in unadjusted as well as adjusted models (p<0.20). Sig-
nificance level was set at 5%. Mean age of prehypertensive subjects 
was 42.6±9.2 years; 60% were females, 33.3% were Black, 61.6% 
were overweight, and 68.3% had a sedentary lifestyle. Endothelial 
dysfunction was detected in 36.7% of the population; its frequency 
was higher for Black subjects (45%). Association was established bet-
ween endothelial dysfunction and males as well as obesity, the latter 
even after adjustment of the model (p=0.010). 
Conclusions: In conclusion, frequency of endothelial dysfunction 
as determined by FMD was high in the population under study, even 
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Introduction
Endothelial dysfunction is associated with atheros-
clerosis progression and complications, and thus it is 
an early marker of cardiovascular disease (CVD). [1]
Endothelial dysfunction as detected by flow-me-
diated vasodilation (FMD) of the brachial artery was 
related to the presence of coronary artery disease 
in 122 subjects undergoing coronary angiography, 
with 71% sensitivity and 81% specificity. [2] The po-
sitive predictive value of abnormal brachial dilation 
with respect to coronary endothelial dysfunction 
is 95%. [3] Therefore, assessment of endothelial 
function can help in the identification of early chan-
ges in asymptomatic subjects with CVD risk factors, 
such as prehypertension.
Despite controversies over the use of the term 
‘prehypertension’, studies have demonstrated 
that this clinical condition is an independent risk 
factor for the development of systemic arterial 
hypertension (SAH) and arteriosclerotic vascular 
disease. [4-7]
Weil et al [8] have shown that, regardless of other 
CVD risk factors, prehypertension is associated with 
decreased blood flow in the forearm in response to 
acetylcholine infusion, suggesting less endothelium-
dependent vasodilation. Moreover, it is known that 
increased age is associated to decreased endothe-
lium-dependent vasodilation in humans and such re-
duction occurs earlier in males than females. [9, 10]
Nevertheless, data on the influence of clinical and 
epidemiological profile of prehypertensive subjects 
on endothelial function is lacking and little is known 
about the relationship between intermediate car-
diovascular phenotypes and race differences. Pulse 
wave velocity seems to be greater in Africans than 
in Europeans. [11] Plavnik et al [12], when compa-
ring the endothelial function of prehypertensive and 
normotensive subjects, have showed no impact of 
body weight on FMD in either group.
This study aimed at evaluating the endothelial 
function of prehypertensive subjects by FMD and in-
vestigating the association of demographic, anthro-
pometric and clinical characteristics with endothelial 
dysfunction.
Methods
Study Design 
This is an analytical cross-sectional study evaluating 
60 male and female subjects aged 30-70 years, re-
cruited from the community, with prehypertension: 
systolic blood pressure (SBP) 120-139 mmHg and/
or diastolic blood pressure (DBP) 80-89 mmHg. [13]
Subjects with diabetes mellitus or known CVD, on 
daily anti-inflammatory drugs within the last 30 
days, smokers (subjects smoking any number of ci-
garettes per day) and pregnant females were not 
enrolled in the study.
Data Collection and Analysis
Subjects who consented to participating in the 
study were asked to fill out a form regarding de-
though subjects were young, non-smoking and non-diabetic, and as-
sociation was established between endothelial dysfunction and obe-
sity.
Keywords
Endothelial Dysfunction; Prehypertension; Flow-Mediated Vasodilation; 
Associated Factors.
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mographics (gender, age and race as reported by 
subject), past medical history and living habits, and 
then underwent physical examination for collection 
of anthropometric measures (weight and height for 
body mass index (BMI) calculation, and abdominal 
circumference (AC).
Previous diagnosis of SAH, diabetes mellitus, dys-
lipidemia, heart diseases and stroke was based on 
information provided by subjects or administration 
of drugs intended to treat such diseases. Sedentary 
lifestyle was defined as less than 150 minutes of 
aerobic physical activity per week. [14]
Weight (kg) and height (m) were measured using 
a calibrated and standardized digital scale (G-tech® 
BALGL200, Providence, RI, USA) and standard mea-
suring tape, in subjects in the standing position and 
barefoot. BMI calculation was based on the equa-
tion: BMI (kg/ m2) = weight (kg)/(height × height) 
(m), and results were presented according to ca-
tegories (underweight, normal weight, overweight 
and obesity class I, II and III). [15]
AC (midpoint between the last rib and iliac 
crest) measurement was also carried out using 
standard measuring tape and results were sorted 
according to values adopted by the National Cho-
lesterol Education Program/Adult Treatment Panel 
III (NCEP/ATP III): >88 cm for females and >102 
cm for males. [16] 
Blood pressure was measured by oscillometry 
with a validated automatic digital device (Omron® 
HEM-7200, Song Jiang Road, China) and cuff adjus-
ted for mid-upper arm circumference, with subjects 
in the sitting position and measurement of the do-
minant arm; results were expressed as average of 
four measurements (two at each visit, considering 
an interval of 7-15 days between them).
In order to evaluate the influence of blood pres-
sure on FMD, subjects were divided into two groups 
according to pressure values: 120 × 80 to 129 × 84 
mmHg (Stage I) and 130 × 85 to 139 × 89 mmHg 
(Stage II), given that in the Framingham Heart Stu-
dy, risk of adverse cardiovascular events was higher 
in the category previously known as high-normal 
pressure (Stage II). [4]
For FMD evaluation, patients were instructed not 
to consume caffeine and not to perform physical 
exercises on the day of examination. Women were 
also instructed to have the examination conducted 
outside their menstrual period. Tests were conduc-
ted in peaceful setting and temperature at around 
20 ºC.
The technique used for analysis of FMD was the 
one proposed by Celermajer et al [17] and modified 
by Montenegro et al [18].
Patients were placed in the supine position, with 
slight abduction of the right arm. Continuous elec-
trocardiographic monitoring was performed for 
synchronization of brachial artery measurements 
with electrocardiographic R wave. Linear transducer 
was placed on the medial aspect of the arm for B-
mode longitudinal image of the brachial artery 5-10 
cm above the antecubital fossa. In order to attest 
to the location of the artery, color flow mapping 
was used and mid-vessel maximum diameter of the 
brachial artery was measured lengthwise in scans 
of proximal and distal lumen-to-intima interfaces. 
Baseline brachial artery diameter (BBAD) was mea-
sured three times. 
Following BBAD measurement, transducer lo-
cation on the skin was marked to measure post-
occlusion brachial artery diameter (POBAD) at the 
same location. Artery occlusion for 5 minutes was 
obtained with pneumatic cuff placed on the arm 
and adjustment of pressure at 50 mmHg above in-
dividual SBP. Brachial artery diameter was recorded 
continuously for 90 s after deflation of cuff. Flow 
rate was obtained before and 15 s after cuff de-
flation and three POBAD measurements were per-
formed at each time point: 30, 60 and 90 s after 
cessation of insufflation (Figure 1).
FMD was calculated by means of the equation: 
FMD (%) = [(POBAD (mm) − BBAD) (mm)/BBAD 
(mm)] × 100. Values >10% were considered nor-
mal. [19-21]
InternatIonal archIves of MedIcIne 
sectIon: cardIovascular BIology
ISSN: 1755-7682
2016
Vol. 9 No. 320
doi: 10.3823/2191
This article is available at: www.intarchmed.com and www.medbrary.com 4
The measure considered as POBAD for FMD cal-
culation was the one obtained at 60 s after the cuff 
deflation. 
FMD testing was conducted in a two-dimensional 
color and spectral Doppler ultrasound device and 
linear probe transducer with frequency 8-11 MHz 
(GE® LOGIQ VP3, Fairfield, CT, USA).
All tests were performed by the same vascular 
surgeon who was blind to clinical characteristics of 
subjects in the study.
Statistical Analysis
Data were analyzed using the software IBM SPSS 
Statistics 20.0 (2011). Significance level was set at 
5%. First, descriptive analysis was conducted. Nor-
mality of quantitative variables was analyzed by 
Lilliefors test. Qualitative variables are presented 
by frequency and percentage whereas quantitative 
variables are presented as mean±s.d. and median. 
In order to evaluate the relationship between en-
dothelial dysfunction and study variables, indepen-
dent Student t (normality), Mann-Whitney (asym-
metry) and independent chi-square tests were em-
ployed. Finally, multivariate logistic regression was 
applied, at first as unadjusted model with respect 
to FMD for odds ratio (OR) and 95% confidence 
interval (CI) estimates, then as adjusted model with 
p<0.20.
Consent and Approval
Study procedures, methods and objectives were 
considered in accordance with ethical standards of 
the Research Ethics Committee of University Hospi-
tal Presidente Dutra, Federal University of Maran-
hão, from which approval was received in Unified 
Opinion # 249 218 (Attachment A). Study partici-
pation was only possible for subjects who signed 
the Informed Consent Form written according to 
provisions in the Brazilian National Health Council 
(CNS) Resolution # 466/12, et seq.
Results
From February 2013 to December 2014, 361 pre-
hypertensive subjects were recruited in SAH colla-
borative efforts and prevention actions. Of these, 
134 met study inclusion criteria and 84 agreed to 
participate in it. There was a loss of 28% of sub-
jects, totaling a population of 60 prehypertensive 
subjects.
Demographic, anthropometric and clinical cha-
racteristics of the study population are presented 
in Table 1. 
Figure 1:  Scans for baseline (PRE) and post-occlu-
sion (60S) brachial artery diameter for 
flow-mediated vasodilation calculation.
Table 1.  Demographic, anthropometric and clinical 
characteristics of the study population.
Variables Values
Gender (%)
Male 40.0
Female 60.0
Mean age (years) 42.6±9.2
Age group (%)
30-39 years 40.0
40-49 years 40.0
50-59 years 15.0
>59 years 5.0
Race (%)
Black 33.3
Brown 33.3
White 33.3
Median BMI (kg m2) 26.1
Overweight (%) 43.3
Obesity (%) 18.3
Mean AC (cm) 90.6±11.4
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Table 4 presents BBAD and POBAD values as well 
as percent change after vessel occlusion (FMD) in 
males and females. 
Association was established between endothelial 
dysfunction and male subjects (p=0.022), as shown 
Figure 2:  Shows mean FMD values for subjects 
with and without endothelial dys-
function.
Table 2.  Blood pressure levels and prehypertension 
stages in the study population.
Blood pressure levels mmHg p value*
Mean blood pressure 126.7±5.9 × 77.1±6.5
<0.01
Median SBP 
All subjects 125.6
Males 131.7
Females 123.5
Prehypertension stages (%)
 I 
(120 × 80 to 129 × 84)
63.3
 II 
(130 × 85 to 139 × 89)
36.7
Total 100.0
SBP: systolic blood pressure. *: According to Mann-Whitney 
test. Data are percentage (%), median, or mean±s.d
Table 4.  Baseline and post-occlusion brachial artery 
diameter and flow-mediated vasodilation 
of the brachial artery according to gender 
in prehypertensive subjects.
Variables Males Females p value
Median BBAD (mm) 3.7 3.0 <0.001a
Median POBAD (mm) 4.0 3.4 <0.001a
Mean FMD (%) 10.3±5.6 14.2±7.7 0.038b
BBAD: baseline brachial artery diameter; POBAD: post-
occlusion brachial artery diameter; FMD: flow-mediated 
vasodilation of the brachial artery. a:According to Mann-
Whitney test; b:According to Student t test. 
Data are median or mean±s.d.
Table 3. Flow-mediated vasodilation of the brachial artery and endothelial dysfunction frequency per race 
in the study population.
FMD
Race
Total
p 
valueWhite % Black % Brown %
Median 11.9
----
12.3
----
12.2
---- ---- 0.865a
Q1/Q3 (%) 8.8/14.3 5.0/16.2 7.8/16.3
> 10% 14 70.0 11 55.0 13 65.0 38
0.605b
≤ 10% 6 30.0 9 45.0 7 35.0 22
FMD: flow-mediated vasodilation of the brachial artery. a:According to Kruskal-Wallis test; b:According to chi-square test
Variables Values
Increased AC (%) 43.3
Dyslipidemia (%) 20.0
Sedentary lifestyle (%) 68.3
BMI: body mass index; AC: abdominal circumference. 
Data are percentage (%), median, or mean±s.d.
Mean blood pressure was 126.7±5.9 × 77.1±6.5 
mmHg and 63.3% of subjects had stage I prehy-
pertension, with statistically significant difference in 
SPB values between genders, as shown in Table 2.
Endothelial dysfunction was detected in 36.7% 
of the population. When assessing the frequency 
of endothelial dysfunction according to the race, 
it can be inferred that 45% of Black subjects had 
endothelial dysfunction when compared to 35% of 
Brown and 30% of White ones (p=0.605) (Table 3).
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in Table 5. However, such association lost its statis-
tical significance following model adjustment with 
respect to other variables. 
On the other hand, in the multivariate logistic re-
gression, endothelial dysfunction was associated to 
obesity in the unadjusted model (p=0.012) as well 
as in the adjusted one (p=0.010) (Table 6).
Discussion
Endothelial dysfunction plays a fundamental role 
in all stages of atherogenesis, from initial injury to 
plaque rupture, leading to acute coronary events. 
[21] It is also known that endothelial dysfunction 
is a generalized process. Therefore, to test nitric 
oxide-mediated vasomotor function of the brachial 
artery allows stratifying asymptomatic individuals at 
increased risk for CVD complications. [22] Approxi-
mately 50% of blood pressure-related deaths occur 
in individuals with SBP 115-140 mmHg, suggesting 
that prehypertension accounts for a significant 
proportion of CVD-related mortality. [23] Thus, it 
is important to identify endothelial dysfunction in 
this population, as this condition could constitute 
Table 6.  Multivariate logistic regression of study variables with respect to flow-mediated vasodilation of 
the brachial artery.
Variables
Unadjusted model Adjusted model
OR CI 95% p value OR CI 95% p value
Male 3.03 0.82-11.29 0.098 3.04 0.88-10.51 0.078
Age >45 years 1.05 0.26-4.30 0.942 - - -
Black race 1.53 0.40-5.92 0.534 - - -
Dyslipidemia 0.70 0.12-4.25 0.701 - - -
Sedentary lifestyle 1.30 0.31-5.52 0.724 - - -
BMI (obese) 11.83 1.72-81.43 0.012 12.10 1.81-80.83 0.010
Increased AC 0.25 0.04-1.77 0.166 0.29 0.05-1.56 0.19
OR: odds ratio; CI: confidence interval; BMI, body mass index; AC, abdominal circumference.
Table 5.  Association between study variables and 
flow-mediated vasodilation of the brachial 
artery.
Variables
FMD* Total
*
p 
value>10% % ≤10% %
Gender
Male 11 28.9 13 59.1 24
0.022†
Female 27 71.1 9 40.9 36
Age group
30-39 15 39.5 9 40.9 24
0.983†
40-49 15 39.5 9 40.9 24
50-59 6 15.8 3 13.6 9
>59 2 5.3 1 4.5 3
Mean age 
(years)
42.4±9.5 ---- 42.9±8.7 ---- ----- 0.861‡
Race
White 14 36.8 6 27.3 20
0.605†Black 11 28.9 9 40.9 20
Brown 13 34.2 7 31.8 20
Prehypertension stages
 I 25 65.8 13 59.1 38
0.604†
 II 13 34.2 9 40.9 22
Sedentary 
lifestyle
26 68.4 15 68.2 41 0.788†
Variables
FMD* Total
*
p 
value>10% % ≤10% %
Dyslipidemia 9 23.7 3 13.6 12 0.546†
Median BMI 
(kg m2)
25.3 ---- 27.5 ---- ---- 0.055§
Mean AC 
(cm)
88.9±11.5 ---- 93.4±11 ---- ---- 0.147‡
FMD: flow-mediated vasodilation of the brachial artery; 
BMI: body mass index; AC: abdominal circumference. 
*: Data are numbers (n), median, or mean±s.d.
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a key mechanism for the development of SAH and 
arteriosclerotic vascular disease. [8]
This study evaluated non-smoking and non-dia-
betic prehypertensive subjects of both genders and 
identified the presence of endothelial dysfunction 
in 36.7% of the population under analysis. Prehy-
pertensive subjects were mainly female, non-White, 
overweight and had a sedentary lifestyle.
In 2007, Plavnik et al [12] have analyzed the 
nitrate-mediated endothelium-dependent and -in-
dependent vasodilation response (FMD) in 33 nor-
motensive subjects compared to 28 normal-high 
blood pressure subjects with age and BMI similar 
to those of the present study and the authors have 
demonstrated a flow-mediated vasodilation res-
ponse about 30% lower in the first group, sugges-
ting endothelial dysfunction at prehypertension 
levels. Nevertheless, there subjects were mainly 
males, and race and sedentary lifestyle were not 
study variables.
Gender frequency differences between both stu-
dies could be explained by recruitment locations of 
individuals such as malls, churches and health cen-
ters in the present study. In both studies, FMD was 
higher in females. It is known that hyperemic sti-
muli are greater in smaller arteries because of their 
smaller radius. Thus, low BBAD values as observed 
in females compared to males may result in higher 
FMD values. [24] Juonala et al [22] have studied car-
diovascular risk in 2 265 subjects aged 24-39 years 
and have also found higher FMD values among fe-
males that were believed to be due to lower BBAD 
values.
Brown and Black subjects accounted for two-
thirds of the study population. Although there 
was no statistical significance probably due to the 
sample size, endothelial dysfunction frequency 
was higher among Black prehypertensive subjects 
compared to White ones. This finding is particu-
larly important as most of the local population is 
non-White and can be at greater risk for develo-
ping CVD complications.
It is noteworthy the percentage of overweight 
and obese subjects, which may reflect an unhealthy 
lifestyle. Two-thirds of prehypertensive subjects in 
the study reported having a sedentary lifestyle, and 
an Israeli study [25] has shown that high BMI was 
the main predictive factor of prehypertension.
There was a tendency of association between 
endothelial dysfunction and increased BMI. And 
according to multivariate analysis, obese subjects 
were more likely to have endothelial dysfunction 
even after adjustment to other variables. Plavnik et 
al [12], when comparing endothelial function of pre-
hypertensive and normotensive subjects, showed 
no impact of body weight on FMD in all groups. 
However, it is known that obesity is a risk factor for 
coronary heart disease. Adipose tissue, particularly 
in the visceral compartment, is an endocrine and 
paracrine organ, a source of pro-inflammatory subs-
tances and mediators capable of causing vascular 
injury and endothelial dysfunction. [26]
Regarding blood pressure, the mean of the study 
population was lower than the one described by 
Plavnik et al [12], and it is noteworthy that 63.3% 
of subjects fall within stage I of prehypertension. 
The predominantly young population, with 80% of 
subjects being 30-49 years old and females, may 
explain this finding.
In the initial analysis, there was association bet-
ween endothelial dysfunction and males, which 
could be explained by differences in SBP values bet-
ween genders. SBP level in males was significantly 
higher than in females, even though both genders 
had similar age and BMI. Plavnik et al12, when stra-
tifying levels of SBP and diastolic blood pressure in 
their groups, have demonstrated a 29% reduction 
in FMD with increasing SBP from 125 mmHg to 139 
mmHg. Nonetheless, this association was not main-
tained after adjustment for the remaining variables.
Regarding FMD among prehypertensive subjects, 
Plavnik et al [12] have found values lower than tho-
se detected in this study, considering both total 
population and prehypertensive subjects without 
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endothelial dysfunction. This difference can be ex-
plained by time points for POBAD measurement 
(90 s × 60 s) in the studies. Maximum increase in 
brachial diameter seems to occur approximately 60 
s after release of blood flow, when 70% of dila-
tion is believed to be due to nitric oxide synthesis. 
[27] Repeated measurements must be performed to 
capture maximum response. [22] Another fact that 
may explain this finding is the difference between 
samples with respect to gender.
It is also known that stimuli should be consistent 
and FMD must be related to the change in blood 
flow. [27] To exclude inconsistencies of ischemic sti-
muli, peak hyperemic flow was measured 15 s after 
cuff deflation, showing that the real increase in flow 
is responsible for vasodilation.
Regarding FMD in prehypertensive subjects with 
endothelial dysfunction, values detected in this stu-
dy are lower than mean values in prehypertensive 
subjects in the study by Plavnik et al [12]. It is no-
teworthy that authors have compared normotensive 
and normal-high pressure subjects and have iden-
tified a FMD reduction in groups without a cut-
off value for endothelial dysfunction diagnosis, as 
carried out in this study.
Currently, wrist or forearm occlusion is used to 
assess endothelial function [28], because it seems 
to express dilation promoted exclusively by nitric oxi-
de. However, location of the cuff does not appear 
to affect method reliability. Most importantly, time 
length between release of flow and post-occlusion 
diameter measurements should be 60 s [24], as per-
formed in this study.
The mechanism responsible for endothelial dys-
function in prehypertensive subjects is not yet 
known. However, inflammation, oxidative stress 
and increased endothelin-1 activity may be involved 
in this process. [8] Additionally, there is evidence of 
a lower capacity for repair of endothelial progenitor 
cells contributing to endothelial dysfunction. [28]
The study design (cross-sectional) is one of its 
limitations, once it doesn´t provide the causal rela-
tionship between prehypertension and endothelial 
dysfunction, besides the sample size.
Conclusively, this study confirms the presence of 
endothelial dysfunction in young, non-smoking and 
non-diabetic prehypertensive subjects with blood 
pressure values lower than those described in other 
studies, especially in Black subjects, which ultimately 
means increased risk for development of CVD. Such 
findings reinforce recent arguments in favor of ear-
lier intervention and treatment of prehypertension.
Since 40% of prehypertensive subjects present 
SAH within two years [29] and conversion risk is 
35% higher in Black individuals compared to Whi-
te ones [30], conducting clinical trials designed to 
better assess racial differences in prehypertension 
prevalence, evolution and prognosis should be con-
sidered.
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